LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: A titratable murine model of progressive emphysema using tracheal porcine pancreatic elastase.

    Joshi, Imani / Devine, Andrew J / Joshi, Rashika / Smith, Noah J / Varisco, Brian M

    Scientific reports

    2023  Volume 13, Issue 1, Page(s) 15259

    Abstract: Progressive emphysema often leads to end-stage lung disease. Most mouse models of emphysema are typically modest (i.e. cigarette smoke exposure), and changes over time are difficult to quantify. The tracheal porcine pancreatic elastase model (PPE) ... ...

    Abstract Progressive emphysema often leads to end-stage lung disease. Most mouse models of emphysema are typically modest (i.e. cigarette smoke exposure), and changes over time are difficult to quantify. The tracheal porcine pancreatic elastase model (PPE) produces severe injury, but the literature is conflicted as to whether emphysema improves, is stable, or progresses over time. We hypothesized a threshold of injury below which repair would occur and above which emphysema would be stable or progress. We treated 8-week-old C57BL6 mixed sex mice with 0, 0.5, 2, or 4 activity units of PPE in 100 µL PBS and performed lung stereology at 21 and 84 days. There were no significant differences in weight gain or mouse health. Despite minimal emphysema at 21-days in the 0.5 units group (2.8 µm increased mean linear intercept, MLI), MLI increased by 4.6 µm between days 21 and 84 (p = 0.0007). In addition to larger MLI at 21 days in 2- and 4-unit groups, MLI increases from day 21 to 84 were 17.2 and 34 µm respectively (p = 0.002 and p = 0.0001). Total lung volume increased, and alveolar surface area decreased with time and injury severity. Contrary to our hypothesis, we found no evidence of alveolar repair over time. Airspace destruction was both progressive and accelerative. Future mechanistic studies in lung immunity, mechano-biology, senescence, and cell-specific changes may lead to novel therapies to slow or halt progressive emphysema in humans.
    MeSH term(s) Humans ; Animals ; Swine ; Mice ; Disease Models, Animal ; Pulmonary Emphysema ; Emphysema ; Acceleration ; Pancreatic Elastase
    Chemical Substances Pancreatic Elastase (EC 3.4.21.36)
    Language English
    Publishing date 2023-09-14
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-023-41527-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: CELA1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency.

    Devine, Andrew J / Smith, Noah J / Joshi, Rashika / Fan, Qiang / Borchers, Michael T / Clair, Geremy C / Adkins, Joshua N / Varisco, Brian M

    Research square

    2023  

    Abstract: Chymotrypsin-like elastase ... ...

    Abstract Chymotrypsin-like elastase 1
    Language English
    Publishing date 2023-02-23
    Publishing country United States
    Document type Preprint
    DOI 10.21203/rs.3.rs-2617812/v1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Chymotrypsin-like Elastase-1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency.

    Devine, Andrew J / Smith, Noah J / Joshi, Rashika / Fan, Qiang / Borchers, Michael T / Clair, Geremy C / Adkins, Joshua N / Varisco, Brian M

    Chronic obstructive pulmonary diseases (Miami, Fla.)

    2023  Volume 10, Issue 4, Page(s) 380–391

    Abstract: Chymotrypsin-like elastase 1 (CELA1) is a serine protease that is neutralized by alpha-1antitrypsin (AAT) and prevents emphysema in a murine antisense oligonucleotide model of AAT-deficient emphysema. Mice with genetic ablation ... ...

    Abstract Chymotrypsin-like elastase 1 (CELA1) is a serine protease that is neutralized by alpha-1antitrypsin (AAT) and prevents emphysema in a murine antisense oligonucleotide model of AAT-deficient emphysema. Mice with genetic ablation of
    Language English
    Publishing date 2023-08-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2771715-X
    ISSN 2372-952X
    ISSN 2372-952X
    DOI 10.15326/jcopdf.2023.0416
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Anti-CELA1 antibody KF4 prevents emphysema by inhibiting stretch-mediated remodeling.

    Ojha, Mohit / Smith, Noah J / Devine, Andrew J / Joshi, Rashika / Goodman, Emily M / Fan, Qiang / Schuman, Richard / Porollo, Aleksey / Wells, J Michael / Tiwary, Ekta / Batie, Matthew R / Gray, Jerilyn / Deshmukh, Hitesh / Borchers, Michael T / Ammerman, Samuel A / Varisco, Brian M

    JCI insight

    2024  Volume 9, Issue 1

    Abstract: There are no therapies to prevent emphysema progression. Chymotrypsin-like elastase 1 (CELA1) is a serine protease that binds and cleaves lung elastin in a stretch-dependent manner and is required for emphysema in a murine antisense oligonucleotide model ...

    Abstract There are no therapies to prevent emphysema progression. Chymotrypsin-like elastase 1 (CELA1) is a serine protease that binds and cleaves lung elastin in a stretch-dependent manner and is required for emphysema in a murine antisense oligonucleotide model of α-1 antitrypsin (AAT) deficiency. This study tested whether CELA1 is important in strain-mediated lung matrix destruction in non-AAT-deficient emphysema and the efficacy of CELA1 neutralization. Airspace simplification was quantified after administration of tracheal porcine pancreatic elastase (PPE), after 8 months of cigarette smoke (CS) exposure, and in aging. In all 3 models, Cela1-/- mice had less emphysema and preserved lung elastin despite increased lung immune cells. A CELA1-neutralizing antibody was developed (KF4), and it inhibited stretch-inducible lung elastase in ex vivo mouse and human lung and immunoprecipitated CELA1 from human lung. In mice, systemically administered KF4 penetrated lung tissue in a dose-dependent manner and 5 mg/kg weekly prevented emphysema in the PPE model with both pre- and postinjury initiation and in the CS model. KF4 did not increase lung immune cells. CELA1-mediated lung matrix remodeling in response to strain is an important contributor to postnatal airspace simplification, and we believe that KF4 could be developed as a lung matrix-stabilizing therapy in emphysema.
    MeSH term(s) Animals ; Humans ; Mice ; Aging ; Elastin ; Emphysema ; Pancreatic Elastase ; Pulmonary Emphysema/prevention & control ; Swine
    Chemical Substances CELA1 protein, mouse (EC 3.4.21.36) ; Elastin (9007-58-3) ; Pancreatic Elastase (EC 3.4.21.36)
    Language English
    Publishing date 2024-01-09
    Publishing country United States
    Document type Journal Article
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.169189
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Structure and Function of the α-Hydroxylation Bimodule of the Mupirocin Polyketide Synthase.

    Winter, Ashley J / Khanizeman, R Nisha / Barker-Mountford, Abigail M C / Devine, Andrew J / Wang, Luoyi / Song, Zhongshu / Davies, Jonathan A / Race, Paul R / Williams, Christopher / Simpson, Thomas J / Willis, Christine L / Crump, Matthew P

    Angewandte Chemie (International ed. in English)

    2023  Volume 62, Issue 47, Page(s) e202312514

    Abstract: Mupirocin is a clinically important antibiotic produced by a trans-AT Type I polyketide synthase (PKS) in Pseudomonas fluorescens. The major bioactive metabolite, pseudomonic acid A (PA-A), is assembled on a tetrasubstituted tetrahydropyran (THP) core ... ...

    Abstract Mupirocin is a clinically important antibiotic produced by a trans-AT Type I polyketide synthase (PKS) in Pseudomonas fluorescens. The major bioactive metabolite, pseudomonic acid A (PA-A), is assembled on a tetrasubstituted tetrahydropyran (THP) core incorporating a 6-hydroxy group proposed to be introduced by α-hydroxylation of the thioester of the acyl carrier protein (ACP) bound polyketide chain. Herein, we describe an in vitro approach combining purified enzyme components, chemical synthesis, isotopic labelling, mass spectrometry and NMR in conjunction with in vivo studies leading to the first characterisation of the α-hydroxylation bimodule of the mupirocin biosynthetic pathway. These studies reveal the precise timing of hydroxylation by MupA, substrate specificity and the ACP dependency of the enzyme components that comprise this α-hydroxylation bimodule. Furthermore, using purified enzyme, it is shown that the MmpA KS
    MeSH term(s) Mupirocin ; Polyketide Synthases/metabolism ; Hydroxylation ; Anti-Bacterial Agents/chemistry
    Chemical Substances Mupirocin (D0GX863OA5) ; Polyketide Synthases (79956-01-7) ; Anti-Bacterial Agents
    Language English
    Publishing date 2023-10-17
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.202312514
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Structure and Function of the α-Hydroxylation Bimodule of the Mupirocin Polyketide Synthase.

    Winter, Ashley J / Khanizeman, R Nisha / Barker-Mountford, Abigail M C / Devine, Andrew J / Wang, Luoyi / Song, Zhongshu / Davies, Jonathan A / Race, Paul R / Williams, Christopher / Simpson, Thomas J / Willis, Christine L / Crump, Matthew P

    Angewandte Chemie (Weinheim an der Bergstrasse, Germany)

    2023  Volume 135, Issue 47, Page(s) e202312514

    Abstract: Mupirocin is a clinically important antibiotic produced by ... ...

    Abstract Mupirocin is a clinically important antibiotic produced by a
    Language English
    Publishing date 2023-10-16
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 506609-8
    ISSN 1521-3757 ; 0044-8249 ; 0932-2140
    ISSN (online) 1521-3757
    ISSN 0044-8249 ; 0932-2140
    DOI 10.1002/ange.202312514
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The Role of Cytochrome P450 AbyV in the Final Stages of Abyssomicin C Biosynthesis.

    Devine, Andrew J / Parnell, Alice E / Back, Catherine R / Lees, Nicholas R / Johns, Samuel T / Zulkepli, Ainul Z / Barringer, Rob / Zorn, Katja / Stach, James E M / Crump, Matthew P / Hayes, Martin A / van der Kamp, Marc W / Race, Paul R / Willis, Christine L

    Angewandte Chemie (International ed. in English)

    2022  Volume 62, Issue 3, Page(s) e202213053

    Abstract: Abyssomicin C and its atropisomer are potent inhibitors of bacterial folate metabolism. They possess complex polycyclic structures, and their biosynthesis has been shown to involve several unusual enzymatic transformations. Using a combination of ... ...

    Abstract Abyssomicin C and its atropisomer are potent inhibitors of bacterial folate metabolism. They possess complex polycyclic structures, and their biosynthesis has been shown to involve several unusual enzymatic transformations. Using a combination of synthesis and in vitro assays we reveal that AbyV, a cytochrome P450 enzyme from the aby gene cluster, catalyses a key late-stage epoxidation required for the installation of the characteristic ether-bridged core of abyssomicin C. The X-ray crystal structure of AbyV has been determined, which in combination with molecular dynamics simulations provides a structural framework for our functional data. This work demonstrates the power of combining selective carbon-13 labelling with NMR spectroscopy as a sensitive tool to interrogate enzyme-catalysed reactions in vitro with no need for purification.
    MeSH term(s) Cytochrome P-450 Enzyme System/metabolism ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Molecular Dynamics Simulation ; Secondary Metabolism
    Chemical Substances abyssomicin C ; Cytochrome P-450 Enzyme System (9035-51-2) ; Bridged Bicyclo Compounds, Heterocyclic
    Language English
    Publishing date 2022-12-08
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.202213053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: The Role of Cytochrome P450 AbyV in the Final Stages of Abyssomicin C Biosynthesis.

    Devine, Andrew J / Parnell, Alice E / Back, Catherine R / Lees, Nicholas R / Johns, Samuel T / Zulkepli, Ainul Z / Barringer, Rob / Zorn, Katja / Stach, James E M / Crump, Matthew P / Hayes, Martin A / van der Kamp, Marc W / Race, Paul R / Willis, Christine L

    Angewandte Chemie (Weinheim an der Bergstrasse, Germany)

    2022  Volume 135, Issue 3, Page(s) e202213053

    Abstract: Abyssomicin C and its atropisomer are potent inhibitors of bacterial folate metabolism. They possess complex polycyclic structures, and their biosynthesis has been shown to involve several unusual enzymatic transformations. Using a combination of ... ...

    Abstract Abyssomicin C and its atropisomer are potent inhibitors of bacterial folate metabolism. They possess complex polycyclic structures, and their biosynthesis has been shown to involve several unusual enzymatic transformations. Using a combination of synthesis and in vitro assays we reveal that AbyV, a cytochrome P450 enzyme from the
    Language English
    Publishing date 2022-12-08
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 506609-8
    ISSN 1521-3757 ; 0044-8249 ; 0932-2140
    ISSN (online) 1521-3757
    ISSN 0044-8249 ; 0932-2140
    DOI 10.1002/ange.202213053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top